ClinicalTrials.Veeva

Menu

Diphenhydramine in Catheter Related Bladder Discomfort

Cairo University (CU) logo

Cairo University (CU)

Status

Invitation-only

Conditions

Catheter Complications

Treatments

Drug: Saline
Drug: DiphenhydrAMINE 50 Mg/mL Injectable Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT06345261
2024-872

Details and patient eligibility

About

Diphenhydramine has H1-antihistamine action, it also possesses anti-muscarinic properties. Thus, diphenhydramine might be able to reduce the problem of catheter related bladder discomfort by inhibiting smooth muscle spasm of the urinary bladder via its anti-muscarinic action .

Enrollment

104 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

male patients aged more than18-80 years ASA I and II , upper ureteric stone removal under general anesthesia r

Exclusion criteria

overactive bladder cognitive impairment a neuropsychological disorder, bladder outflow obstruction urinary tract infection, , neurogenic bladder, operative time > 6 h

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

104 participants in 2 patient groups, including a placebo group

Diphenhydramine group
Active Comparator group
Treatment:
Drug: DiphenhydrAMINE 50 Mg/mL Injectable Solution
control group
Placebo Comparator group
Treatment:
Drug: Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems